Formulation and Evaluation of Haloperidol Decanoate Containing Transdermal Patch for the Treatment of Psychosis

Authors

  • Arpita Srivastava
  • Kapil Malviya
  • Naveen Gupta
  • Dharmendra Rajput
  • Ankita Shukla

Keywords:

Transdermal drug delivery system, Patch, Film, haloperidol decanoate, Natural polymer

Abstract

Transdermal patches are a non-invasive method of drug administration. It is an adhesive patch designed to deliver a specific dose of medication through the skin and into the bloodstream throughout the body. Transdermal drug delivery has several advantages over other routes of administration, for instance, it is less invasive, patient-friendly, and has the ability to bypass first-pass metabolism and the destructive acidic environment of the stomach that occurs upon the oral ingestion of drugs. For decades, transdermal patches have attracted attention and were used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various diseases or conditions. Recently, this method is also being explored as a means of delivering biologics in various applications. The most common routes of drug delivery are the oral and parenteral routes with the majority of small molecule drugs conventionally delivered orally. The oral route has the advantage of pre-determined doses, portability and patient self-administration. For these reasons, the oral route remains the most convenient means of delivering medications

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Zhang L. and S. Mao, Application of quality by design in the current drug development, As. J. Pharm. Sci. 12 (2017) 1–8;

Wong WF, Ang KP, Sethi G, Looi CY. Recent Advancement of Medical Patch for Transdermal Drug Delivery. Medicina (Kaunas). 2023 Apr 17;59(4):778.

Sharma PK, Panda A, Pradhan A, Zhang J, Thakkar R, Whang CH, Repka MA, Murthy SN. Solid-State Stability Issues of Drugs in Transdermal Patch Formulations. AAPS PharmSciTech. 2018 Jan;19(1):27-35.

Al Hanbali OA, Khan HMS, Sarfraz M, Arafat M, Ijaz S, Hameed A. Transdermal patches: Design and current approaches to painless drug delivery. Acta Pharm. 2019 Jun 1;69(2):197-215.

Stevens JR, Justin Coffey M, Fojtik M, Kurtz K, Stern TA. The Use of Transdermal Therapeutic Systems in Psychiatric Care: A Primer on Patches. Psychosomatics. 2015 Sep-Oct;56(5):423-44. doi: 10.1016/j.psym.2015.03.007. Epub 2015 Apr 1. PMID: 26211981.

Prausnitz M. R. and R. Langer, Transdermal drug delivery, Nat. Biotechnol. 26 (2008) 1261–1268; https://doi.org/10.1038/nbt.1504

Tsai M. J., I. J. Lu, Y. S. Fu, Y.P. Fang, Y. B. Huang and P. C. Wu, Nanocarriers enhance the transdermal bioavailability of resveratrol: In-vitro and in-vivo study, Colloids Surf. B Biointerfaces 148 (2016) 650–656; https://doi.org/10.1016/j.colsurfb.2016.09.045

Simon A. and Amaro M. I., A. M. Healy, L. M. Cabral and V. P. de Sousa, Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation, Int. J. Pharm. 512 (2016) 234–241;

Pridgen E. M., Alexis F. and Farokhzad O. C., Polymeric nanoparticle drug delivery technologies for oral delivery applications, Expert Opin. Drug. Deliv. 12 (2015) 1459–1473;

Arafat M., Approaches to achieve an oral controlled release drug delivery system using polymers: a recent review, Int. J. Pharm. Pharm. Sci. 7 (2015) 16–21.

Gannu R., Y. V. Vishnu, V. Kishan and Y. M. Rao, Development of nitrendipine transdermal patches: in vitro and ex vivo characterization, Curr. Drug Deliv. 4 (2007) 69–76.

Citrome L, Zeni CM, Correll CU. Patches: Established and Emerging Transdermal Treatments in Psychiatry. J Clin Psychiatry. 2019 Jul 16;80(4):18nr12554.

Dumitriu Buzia O, Păduraru AM, Stefan CS, Dinu M, Cocoș DI, Nwabudike LC, Tatu AL. Strategies for Improving Transdermal Administration: New Approaches to Controlled Drug Release. Pharmaceutics. 2023 Apr 7;15(4):1183.

Cutler AJ, Suzuki K, Starling B, Balakrishnan K, Komaroff M, Castelli M, Meeves S, Childress AC. Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study. J Child Adolesc Psychopharmacol. 2022 Mar;32(2):89-97.

Suksaeree J., Monton C., Madaka F., Chusut T., Formulation, physicochemical characterization, and in vitro study of chitosan/HPMC blends-based herbal blended patches, AAPS Pharm. Sci. Tech. 16 (2015) 171–181.

...

Downloads

Published

2025-05-07

How to Cite

1.
Srivastava A, Malviya K, Gupta N, Rajput D, Shukla A. Formulation and Evaluation of Haloperidol Decanoate Containing Transdermal Patch for the Treatment of Psychosis. J Neonatal Surg [Internet]. 2025May7 [cited 2025Sep.21];14(21S):408-1. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/5305

Most read articles by the same author(s)